following established dietary recommendations without the use of dietary supplements for RA management. This recommendation pertains to all dietary supplements considered (as listed in Table 1 Body weight and weight loss Given the broad spectrum of weight loss interventions, including lifestyle modification, commercial weight loss programs, pharmacologic therapies, and surgical interventions, the Voting Panel did not vote on recommendations regarding weight loss interventions specifically for RA management in overweight or obese people with RA. However, the Voting Panel was unanimous in its support of clinicians engaging in discussion about maintaining a healthy body weight for individuals with RA, in order to optimize long-term RA and general health outcomes. In RA, obesity is associated with higher disease activity, impairments in physical function, and poorer treatment response, in addition to poor long-term health outcomes Additional integrative intervention recommendations (Table